Rocket


Overview
Financials
News + Filings
Key Docs
Ownership





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

RedHill Biopharma Ltd. (RDHL)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsMar-31-21Mar-31-20Sep-30-19Mar-31-19Sep-30-18Mar-31-18Mar-31-17
   6-K6-K6-K6-K6-K6-K6-K
Revenues:  
    Commercial Operations U.S. dollars in thousands  1.1 1.41.72.22.4 
    Other  19.5      
Revenues  20.61.11.41.72.22.40.0
            Revenue growth   [+]1848.4%-39.2%-36.5%-29.0%   
Cost of goods sold  10.31.70.60.40.60.9-19.6
Gross profit  10.3-0.70.81.31.61.519.6
            Gross margin  50.2%-62.4%55.1%76.0%72.9%62.0% 
Selling, general and administrative   [+]21.013.62.92.01.71.91.3
Research and development  7.52.82.85.46.66.48.1
Other operating expenses  -36.3-34.0-14.8-15.3-16.4-16.80.0
EBIT   [+]18.217.09.89.29.710.010.1
            EBIT margin  88.2%1611.4%702.6%530.4%441.3%408.8% 
Other income (expense), net  -18.2-17.0-9.8-9.2-9.7-10.0-10.1
Pre-tax income  0.00.00.00.00.00.00.0
Income taxes  0.00.00.00.00.00.00.0
Net income  0.00.00.00.00.00.00.0
            Net margin  0.0%0.0%0.0%0.0%0.0%0.0% 
   
   
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy